Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents.
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002729:Chloromercuribenzoates / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D004091:Hydromorphone / Q000378:metabolism; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D007977:Levallorphan / Q000378:metabolism; D007981:Levorphanol / Q000378:metabolism; D009270:Naloxone / Q000378:metabolism; D009292:Narcotic Antagonists / Q000378:metabolism*; D009294:Narcotics / Q000378:metabolism*; D010111:Oxymorphone / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug; D013329:Structure-Activity Relationship; D013439:Sulfhydryl Reagents / Q000494:pharmacology*; D014316:Tritium
D002729:Chloromercuribenzoates; D007461:Iodoacetates; D009292:Narcotic Antagonists; D009294:Narcotics; D011955:Receptors, Drug; D013439:Sulfhydryl Reagents; D014316:Tritium; D007981:Levorphanol; D007977:Levallorphan; D009270:Naloxone; D010111:Oxymorphone; D005033:Ethylmaleimide; D004091:Hydromorphone